Large-scale proteogenomics characterization of microproteins in Mycobacterium tuberculosis

Abstract Tuberculosis remains a burden to this day, due to the rise of multi and extensively drug-resistant bacterial strains. The genome of Mycobacterium tuberculosis (Mtb) strain H37Rv underwent an annotation process that excluded small Open Reading Frames (smORFs), which encode a class of peptide...

詳細記述

書誌詳細
出版年:Scientific Reports
主要な著者: Eduardo V. de Souza, Pedro F. Dalberto, Adriana C. Miranda, Alan Saghatelian, Antonio M. Pinto, Luiz A. Basso, Pablo Machado, Cristiano V. Bizarro
フォーマット: 論文
言語:英語
出版事項: Nature Portfolio 2024-12-01
オンライン・アクセス:https://doi.org/10.1038/s41598-024-82465-w
その他の書誌記述
要約:Abstract Tuberculosis remains a burden to this day, due to the rise of multi and extensively drug-resistant bacterial strains. The genome of Mycobacterium tuberculosis (Mtb) strain H37Rv underwent an annotation process that excluded small Open Reading Frames (smORFs), which encode a class of peptides and small proteins collectively known as microproteins. As a result, there is an overlooked part of its proteome that is a rich source of potentially essential, druggable molecular targets. Here, we employed our recently developed proteogenomics pipeline to identify novel microproteins encoded by non-canonical smORFs in the genome of Mtb using hundreds of mass spectrometry experiments in a large-scale approach. We found protein evidence for hundreds of unannotated microproteins and identified smORFs essential for bacterial survival and involved in bacterial growth and virulence. Moreover, many smORFs are co-expressed and share operons with a myriad of biologically relevant genes and play a role in antibiotic response. Together, our data presents a resource of unknown genes that play a role in the success of Mtb as a widespread pathogen.
ISSN:2045-2322